Biological brain age and resilience in cognitively unimpaired 70-year-old individuals
- PMID: 39704304
- PMCID: PMC11848408
- DOI: 10.1002/alz.14435
Biological brain age and resilience in cognitively unimpaired 70-year-old individuals
Abstract
Introduction: This study investigated the associations of brain age gap (BAG)-a biological marker of brain resilience-with life exposures, neuroimaging measures, biological processes, and cognitive function.
Methods: We derived BAG by subtracting predicted brain age from chronological age in 739 septuagenarians without dementia or neurological disorders. Robust linear regression models assessed BAG associations with life exposures, plasma inflammatory and metabolic biomarkers, magnetic resonance imaging, and cerebrospinal fluid biomarkers of neurodegeneration and vascular brain injury, and cognitive performance.
Results: Greater BAG (older-looking brains) was associated with physical inactivity, diabetes, and stroke, while prediabetes was related to lower BAG, that is, younger-looking brains. Physical activity mitigated the link between obesity and BAG. Greater BAG was associated with greater small vessel disease burden, white-matter alterations, inflammation, high glucose, poorer vascular-related cognitive domains. Sex-specific associations were identified.
Discussion: Vascular-related lifestyles and health shape brain appearance. Inflammation and insulin-related processes may be keys to understanding vascular cognitive disorders.
Highlights: BAG, reflecting deviations from CA, can indicate resilience. Diabetes, stroke, and low physical activity link to "older" brains (greater BAG). Physical activity yielded to "younger" brains in septuagenarians with obesity. High cerebrovascular burden, inflammation, and glucose associate with "older" brains. Sex differences were detected in all BAG-associated factors.
Keywords: Alzheimer's disease; brain age; fluid biomarkers; glucose; inflammation; resilience; sex differences; small vessel disease; vascular cognitive impairment.
© 2024 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
S.K. has served on scientific advisory boards, speaker and/or as consultant for Roche, Geras Solutions, Optoceutics, Eli Lilly, Biogen and Bioarctic. The remaining authors have nothing to disclose. Author disclosures are available in the Supporting Information.
Figures


References
MeSH terms
Substances
Grants and funding
- Swedish Research Council for Health, Working Life and Welfare (FORTE)
- Eivind och Elsa K:son Sylvans stiftelse
- Collaboratory on Research Definitions for Cognitive Reserve and Resilience
- Swedish Research Council (VR)
- Center for Innovative Medicine (CIMED)
- Swedish Society for Medical Research
- Swedish Alzheimer's Foundation
- Swedish Research Council
- Swedish Brain Foundation
- Swedish Parkinson's foundation
- King Gustaf V:s and Queen Victoria's Foundation, and Olle Engkvists stiftelsen
- Svenska Sällskapet för Medicinsk Forskning
- Demensfonden
- Olle Engkvists Stiftelse
- Stiftelsen för Gamla Tjänarinnor
- Loo och Hans Ostermans Stiftelse
- David och Astrid Hageléns Stiftelse
- 2024-2025/Karolinska Institutet Research
- Strategic Research Area Neuroscience (StratNeuro)
- Foundation for Geriatric Diseases at Karolinska Institutet
- regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet
- Swedish state under the agreement between the Swedish government and the county council of Västra Göraland, the ALF-agreement
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous